Dr. Reddy's Laboratories

Top Analyst Upgrades & Downgrades (NLY, MT, BP, CBOE, DMD, RDY, ING, MS, NOV, OPEN, SOHU, UBS, VSH, YUM)

Credit Suisse Downgrades Dr. Reddy's Laboratories (RDY) to Neutral

Dr. Reddy's downgraded to Neutral from Outperform at Credit Suisse (pre-open)

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca - Press Releases

Sell Dr Reddys Labs; target of Rs 1519: PINC Research

Nomura maintains `Buy` on Dr Reddy`s Laboratories

Dr. Reddy's Laboratories' CEO Discusses Q3 2012 Results - Earnings Call Transcript

Dr Reddy's Laboratories net profit soars 88%

Dr. Reddys Labs (RDY) Reports Q3 Earnings of $0.60

Dr. Reddy's Labs has 33 new generic launches in Q3

Dr. Reddy’s Q3 FY12 Financial Results

Dr Reddy's Labs PAT likely to soar 55.5% in Q3

Diversified Investment Appeal From Novartis (NVS, GSK, MRK, TEVA)

Buy Dr Reddys Labs on dips: Sukhani

Buy Dr Reddys Labs on dips: Sukhani...

Dr. Reddy’s Laboratories (RDY) Comments on Recent Media Reports

Dr. Reddy's Labs clarifies media reports

Dr. Reddy’s Clarifies Media Reports

Dr. Reddy's Laboratories, Inc. (Fondaparinux Sodium Solution for subcutaneous injection)

Dr. Reddy's to Release Q3 FY12 Results on February 3, 2012

6 Pharma Firms, Including Lupin Pharmaceuticals, Inc., Ranbaxy Pharmaceuticals Inc. and Dr. Reddy's Laboratories, Inc. Ally to Improve Efficiency

Dr. Reddy's Laboratories' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Teva and Dr. Reddy’s Announce Launch of Generic Zyprexa® in the United States

Dr. Reddys Laboratories Ltd. (RDY) Reports Q2 Earnings of $0.40

Dr. Reddy’s Q2 FY12 Financial Results

Dr. Reddy’s Announces the Launch of Rivastigmine Tartrate Capsules

Dr. Reddy's Laboratories Ltd.'s May Buy Russian Drugmaker

Dr. Reddy’s Announces Start of Phase II Study with the CETP Inhibitor, DRL-17822 in Dyslipidemia Patients

Dr. Reddy’s Labs (RDY) Announces Settlement Agreement Related to Lipitor with Pfizer (PFE)

Dr. Reddy’s Announces Settlement of Lipitor® (atorvastatin) ANDA Litigation with Pfizer

Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine HCl and Pseudoephedrine HCl Extended Release Tablets

Dr. Reddy's Laboratories, Inc.'s Recalls Contaminated Simvastatin in the US

Fujifilm Holdings to form a JV with Dr Reddy's Laboratories to develop generic drugs for the Japanese market

Dr. Reddys Labs (RDY) Reports Q1 Earnings of $0.35, Stronger Y/Y

Dr Reddy's Labs' net profit moves up by 25% in Q1

Dr. Reddy's Laboratories, Inc.'s Announces the FDA Approval of Fondaparinux Sodium Injection

US FDA Slaps Import Ban On Products From Dr. Reddy's Laboratories Ltd.'s Mexico Plant

Zacks Bull and Bear of the Day Highlights: Cabot Oil & Gas, JDS Uniphase, Dr. Reddy's Laboratories, Pfizer and Novartis AG

Dr Reddy's Laboratories Launches 3 Generic Drugs In US